A method to quantitate the neutralizing capacity of anti-therapeutic protein antibodies in serum and their correlation to clinical impact

- Describes a method to quantitate clinically relevant neutralizing anti-drug antibodies.
- Makes easier comparison and correlation of NAbs within and/or across studies.
- Method can be used across different platforms routinely used for NAb detection.
- Useful across multiple therapeutic targets and analytical methods for standardization.
- Useful in characterization of NAb positive controls for consistent and high quality reagents.